))
Ep 28: How AI is Rewriting Blood Testing (From Panels to 10,000+ Biomarkers) || Jeff Lawy
Manage episode 505557969 series 3452628
Content provided by Jacintha Kurniawan. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jacintha Kurniawan or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Jeff Lawy (Head of Deep Tech Commercialization, Ashera Health) joins me to explore how AI is transforming blood testing, from a handful of biomarkers to 10,000+ signals that actually help you act. We talk about turning complex lab data into clear, personalized guidance, building guardrails around LLMs, and why women’s health (fertility, perimenopause, menopause) is the smartest first focus. We also hit the practical stuff: at-home blood collection (FDA + Health Canada cleared via partner), MVP over perfection, pricing, and getting vendor-approved.
What we cover:
- Scaling from standard panels to 10k+ biomarkers (hormones, endocrine disruptors, “forever chemicals”)
- Personalization vs population averages, and a three-tier reporting model
- Human-in-the-loop AI: where automation ends and clinicians begin
- Launch plans in US & Canada, plus why costs fall over time
- Bonus: space tech, agritech, quantum, why sensor data and falling costs matter
Links
Jeff Lawy: https://www.linkedin.com/in/jeff-lawy/
28 episodes
Share
